2-tert-butylhydroquinone has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cha, Y; Kim, J; Kim, S; Koh, K | 1 |
Huang, B; Li, H; Lin, W; Wang, Z; Wu, S; Zhang, C | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
tBHQ inhibits LPS-induced microglial activation via Nrf2-mediated suppression of p38 phosphorylation.
Topics: Animals; Antioxidants; Cell Death; Cell Line; Culture Media, Conditioned; Cytoprotection; Hydroquinones; Lipopolysaccharides; Mice; Microglia; Neurodegenerative Diseases; Neurons; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Phosphorylation | 2009 |
Neuroprotective effects of tert-butylhydroquinone on paraquat-induced dopaminergic cell degeneration in C57BL/6 mice and in PC12 cells.
Topics: Animals; Apoptosis; Base Sequence; Dopaminergic Neurons; Gene Expression Regulation, Enzymologic; Heme Oxygenase-1; Hydroquinones; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Motor Activity; Neurodegenerative Diseases; Neuroprotective Agents; NF-E2-Related Factor 2; Paraquat; PC12 Cells; Rats; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |